Apretude HIV prevention injectable

Officials at the Food and Drug Administration (FDA) have announced the approval of the first injectable, HIV preexposure prophylaxis (PrEP) drug. The drug is called Apretude and it’s taken every 2 months to reduce the chance of sexually acquired HIV. “Today’s approval adds an important tool in the effort to end the HIV epidemic by providing the first option to prevent HIV that does not involve taking a daily pill,” […]